Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Oxygen Levels Do Not Determine Radiation Survival of Breast Cancer Stem Cells

Published: Thursday, April 12, 2012
Last Updated: Thursday, April 12, 2012
Bookmark and Share
Today, oxygen is recognized to be one of the most powerful radiation sensitizers. This study outlines research into how breast cancer stem cells are protected from radiation through expression of free radical scavengers, with little increase provided by hypoxia.

Abstract
For more than a century oxygen has been known to be one of the most powerful radiosensitizers. However, despite decades of preclinical and clinical research aimed at overcoming tumor hypoxia, little clinical progress has been made so far. Ionizing radiation damages DNA through generation of free radicals. In the presence of oxygen these lesions are chemically modified, and thus harder to repair while hypoxia protects cells from radiation (Oxygen enhancement ratio (OER)). Breast cancer stem cells (BSCSs) are protected from radiation by high levels of free radical scavengers even in the presence of oxygen. This led us to hypothesize that BCSCs exhibit an OER of 1. Using four established breast cancer cell lines (MCF-7, T47D, MDA-MB-231, SUM159PT) and primary breast cancer samples, we determined the number of BCSCs using cancer stem cell markers (ALDH1, low proteasome activity), compared radiation clonogenic survival and mammosphere formation under normoxic and hypoxic conditions, and correlated these results to the expression levels of key members of the free radical scavenging systems. The number of BCSCs increased with increased aggressiveness of the cancer. This correlated with increased radioresistance (SF8Gy), and decreasing OERs. When cultured as mammospheres, breast cancer cell lines and primary samples were highly radioresistant and not further protected by hypoxia (OER,1). We conclude that because BCSCs are protected from radiation through high expression levels of free radical scavengers, hypoxia does not lead to additional radioprotection of BCSCs.

This article was published in PLoS ONE and is free to access online.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biobanking in a Constantly Developing Medical World
Biomaterial resources such as tissues, cells, blood, and serum have played a critical role in academic research.
Wednesday, November 06, 2013
International Heart Valve Bank Survey: A Review of Processing Practices and Activity Outcomes
Since the first heart valve bank (HVB) started in New Zealand in 1962, the recovery, processing, and storage techniques have been constantly evolving.
Wednesday, November 06, 2013
Developing a Semantically Rich Ontology for the Biobank-Administration Domain
Recent research has provided compelling examples of using semantic web technologies, such as ontologies, to retrieve research-relevant data from biobanks.
Tuesday, October 15, 2013
Patient Understanding and Awareness of their Roles as Research Stakeholders in a Cancer Biobank
A patient’s informed consent should imply that the patient has received complete information and fully understands its meaning.
Tuesday, September 10, 2013
Telethon Network of Genetic Biobanks: a Key Service for Diagnosis and Research on Rare Diseases
Recent advances in the technology of molecular biology and genetics have contributed to raise the awareness of the importance of coordinated biobanking activity.
Tuesday, September 10, 2013
Synthetic Surface for Expansion of Human Mesenchymal Stem Cells in Xeno-Free, Chemically Defined Culture
This study evaluates the ability of the Corning Synthemax Surface to support long-term expansion of hMSCs in serum-free, defined medium.
Friday, August 16, 2013
Cryopreservation Causes Genetic and Epigenetic Changes in Zebrafish Genital Ridges
Recent studies have pointed out that cryopreservation can cause molecular alterations in cells at different levels that may interfere with normal embryo development.
Thursday, July 18, 2013
BioBanking as the Central Tool for Translational Medicine
Global healthcare changes forms the basis for the rapid development of centralized large scale biobank facilities.
Monday, June 24, 2013
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
Current research developments and future healthcare solutions are expected to be closely linked to the utility of biobank initiatives.
Friday, March 22, 2013
Effect of Different Freezing Rates During Cryopreservation of Rat MSCs using Combinations of HES and DMSO
In this study researchers from Fraunhofer Institute for Cell Therapy and Immunology attempt an initial comparison of two independent factors: freezing rates and cryopreservation.
Thursday, November 08, 2012
Cryopreserved Reticulocytes Derived from Stem Cells can be Invaded by Cryopreserved Plasmodium vivax Isolates
The cryopreservation method described in this paper provides a continuous and substantial source of reticulocytes, possibly a first step to achieve the continuous in vitro culture of P. vivax.
Wednesday, November 07, 2012
New national Biobank of The Danish Center for Strategic Research on Type 2 Diabetes
This paper aims to describe the biobank logistics and how the biological samples are collected, handled, shipped and stored.
Friday, November 02, 2012
Human Blood RNA Stabilization in Samples Collected and Transported for a Large Biobank
The study strongly suggests that special collection tubes are necessary for RNA stabilization and they should be used for establishing new biobanks.
Friday, October 05, 2012
Biobanking for Health Research in Brazil: Present Challenges and Future Directions
This article outlines and discusses Brazil's new regulations on the use of human biological materials for research.
Monday, September 10, 2012
Evaluation of Distinct Freezing Methods and Cryoprotectants for Human Amniotic Fluid Stem Cells Cryopreservation
Researchers from the University of São Paulo Medical School have evaluated the effects of two cryopreservation methods and four distinct cryoprotectants in the AFSCs viability and main characteristics maintenance after liquid nitrogen storage.
Monday, August 06, 2012
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!